Blood-thinning drug predicted to save lives

A new blood-thinning drug could help to prevent tens of thousands of deaths due to blood clots.

The drug, known as Pradaxa (dabigatran etexilate), received its licence today and will become available to hospitals within weeks.

It will be used initially to prevent clots after hip and knee replacement surgery when the risk of blood clotting is high.

But the hope is that the drug will open the door to more effective treatments for thousands of other patients at risk of heart conditions and strokes.

Currently, the number of deaths linked to blood clots accounts for one in 10 of all deaths in UK hospitals.

Beverly Hunt, medical director of the UK thrombosis charity Lifeblood , said: ‘The development of new drugs to treat blood clots is terribly exciting.

‘The potential benefit to the NHS is enormous.’

sanjay.tanday@haymarket.com

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Before commenting please read our rules for commenting on articles.

If you see a comment you find offensive, you can flag it as inappropriate. In the top right-hand corner of an individual comment, you will see 'flag as inappropriate'. Clicking this prompts us to review the comment. For further information see our rules for commenting on articles.

comments powered by Disqus